S. V. Villevalde

6.1k total citations
109 papers, 383 citations indexed

About

S. V. Villevalde is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Nephrology. According to data from OpenAlex, S. V. Villevalde has authored 109 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cardiology and Cardiovascular Medicine, 34 papers in Epidemiology and 13 papers in Nephrology. Recurrent topics in S. V. Villevalde's work include Healthcare Systems and Public Health (24 papers), Blood Pressure and Hypertension Studies (23 papers) and Cardiovascular Function and Risk Factors (15 papers). S. V. Villevalde is often cited by papers focused on Healthcare Systems and Public Health (24 papers), Blood Pressure and Hypertension Studies (23 papers) and Cardiovascular Function and Risk Factors (15 papers). S. V. Villevalde collaborates with scholars based in Russia, United States and Tajikistan. S. V. Villevalde's co-authors include Zhanna Kobalava, A. E. Soloveva, Н. Э. Звартау, A. N. Yakovlev, Yu. V. Kotovskaya, Marat Fudim, Е. V. Shlyakhto, Ж. Д. Кобалава, Andrew P. Ambrosy and А. S. Galyavich and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

S. V. Villevalde

80 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. V. Villevalde Russia 11 228 132 54 36 35 109 383
Alireza Moaref Iran 12 179 0.8× 97 0.7× 98 1.8× 36 1.0× 28 0.8× 62 412
Christopher Ll. Morgan United Kingdom 7 220 1.0× 55 0.4× 41 0.8× 30 0.8× 13 0.4× 9 388
Erina Ghosh United States 10 197 0.9× 90 0.7× 72 1.3× 35 1.0× 20 0.6× 27 400
François Diévart France 9 191 0.8× 70 0.5× 49 0.9× 34 0.9× 19 0.5× 23 413
Maria F. Paton United Kingdom 13 418 1.8× 95 0.7× 65 1.2× 41 1.1× 71 2.0× 49 643
Matthew C. Konerman United States 13 235 1.0× 71 0.5× 129 2.4× 17 0.5× 9 0.3× 46 456
Marina De Marco Italy 14 463 2.0× 49 0.4× 78 1.4× 41 1.1× 43 1.2× 23 566
Judith E. Lowry United Kingdom 11 293 1.3× 83 0.6× 46 0.9× 19 0.5× 71 2.0× 22 472
Vesna Degoricija Croatia 12 162 0.7× 116 0.9× 93 1.7× 27 0.8× 6 0.2× 50 452
Takafumi Ichikawa Japan 12 148 0.6× 22 0.2× 76 1.4× 22 0.6× 36 1.0× 45 409

Countries citing papers authored by S. V. Villevalde

Since Specialization
Citations

This map shows the geographic impact of S. V. Villevalde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. V. Villevalde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. V. Villevalde more than expected).

Fields of papers citing papers by S. V. Villevalde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. V. Villevalde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. V. Villevalde. The network helps show where S. V. Villevalde may publish in the future.

Co-authorship network of co-authors of S. V. Villevalde

This figure shows the co-authorship network connecting the top 25 collaborators of S. V. Villevalde. A scholar is included among the top collaborators of S. V. Villevalde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. V. Villevalde. S. V. Villevalde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Звартау, Н. Э., A. E. Soloveva, Ksenia Zagorodnikova, et al.. (2025). Preferential drug program for patients within the federal project for control of cardiovascular diseases: implementation strategy, results and prospects. Russian Journal of Cardiology. 30(6). 6391–6391.
2.
Shlyakhto, Е. V., С. В. Недогода, А. Yu. Babenko, et al.. (2025). Concept of an interdisciplinary consensus document on cardiovascular-renal-hepatic-metabolic syndrome. Russian Journal of Cardiology. 30(1S). 6533–6533.
3.
Звартау, Н. Э., S. V. Villevalde, А. О. Конради, et al.. (2025). Management of health care for patients with heart failure in the Northwestern, North Caucasian, Volga and Southern Federal Districts of the Russian Federation: 6-year changes and future prospects. Russian Journal of Cardiology. 30(3). 6276–6276.
4.
Звартау, Н. Э., et al.. (2025). Management of health care for acute coronary syndrome within the federal project "Control of Cardiovascular Diseases": results and prospects. Russian Journal of Cardiology. 30(9). 6405–6405.
5.
Soloveva, A. E., et al.. (2025). Profiling Hypotension in Heart Failure Based on Office, Orthostatic and Ambulatory Blood Pressure Measurements. European Journal of Heart Failure. 27(9). 1695–1696.
6.
7.
8.
9.
Mareev, Yu. V., М. В. Ежов, S. V. Villevalde, et al.. (2023). Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts. Kardiologiia. 63(2). 11–18. 2 indexed citations
10.
Soloveva, A. E., et al.. (2022). Frequency of hemodynamic response to orthostatic stress in heart failure with reduced ejection fraction, associations with clinical blood pressure. SHILAP Revista de lepidopterología. 27(2S). 5005–5005. 1 indexed citations
11.
Ткачева, О. Н., Yu. V. Kotovskaya, Н. К. Рунихина, et al.. (2021). Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology. SHILAP Revista de lepidopterología. 17(4). 642–661. 7 indexed citations
12.
Shlyakhto, Е. V., S. V. Villevalde, Andrey Ezhov, et al.. (2020). Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2. Russian Journal of Cardiology. 25(11). 4179–4179.
13.
Shlyakhto, Е. V., S. V. Villevalde, Andrey Ezhov, et al.. (2020). Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2. SHILAP Revista de lepidopterología. 25(11). 4179–4179. 1 indexed citations
14.
Shlyakhto, Е. V., Н. Э. Звартау, S. V. Villevalde, et al.. (2019). Cardiovascular risk management system: prerequisites for developing, organization principles, target groups. SHILAP Revista de lepidopterología. 69–82. 41 indexed citations
15.
Kobalava, Zhanna, А. О. Конради, С. В. Недогода, et al.. (2018). Russian Society of Cardiology position paper on 2018 Guidelines of the European Society of Cardiology/European Society of Arterial Hypertension for the management of arterial hypertension. Russian Journal of Cardiology. 131–142. 27 indexed citations
16.
Кобалава, Ж. Д., et al.. (2018). Statins associated diabetes: state of the problem in 2018. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Кобалава, Ж. Д., et al.. (2018). Problems of anticoagulation therapy in patients with chronic heart failure and atrial fibrillation: role of rivaroxaban. Kardiologiia. 17(S2). 33–41. 1 indexed citations
18.
Kobalava, Zhanna, et al.. (2014). Biomarkers of acute kidney injury: Current views and prospects. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Villevalde, S. V., et al.. (2013). Value biomarker diagnosis and prediction of acute renal damage in patients with acute coronary syndromes without ST-segment elevation. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Villevalde, S. V., et al.. (2011). Statins in primary prophylaxis of cardiovascular diseases. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alireza Moaref Breakdown of academic impact, for papers by Christopher Ll. Morgan Breakdown of academic impact, for papers by Erina Ghosh Breakdown of academic impact, for papers by François Diévart Breakdown of academic impact, for papers by Maria F. Paton Breakdown of academic impact, for papers by Matthew C. Konerman Breakdown of academic impact, for papers by Marina De Marco Breakdown of academic impact, for papers by Judith E. Lowry Breakdown of academic impact, for papers by Vesna Degoricija Breakdown of academic impact, for papers by Takafumi Ichikawa
Rankless by CCL
2026